| Literature DB >> 29739901 |
Yan Zhang1, Arthur Brady1, Cheron Jones1, Yang Song1, Thomas C Darton2,3, Claire Jones2,3, Christoph J Blohmke2,3, Andrew J Pollard2,3, Laurence S Magder4, Alessio Fasano5, Marcelo B Sztein6, Claire M Fraser7,8,9.
Abstract
Insights into disease susceptibility as well as the efficacy of vaccines against typhoid and other enteric pathogens may be informed by better understanding the relationship between the effector immune response and the gut microbiota. In the present study, we characterized the composition (16S rRNA gene profiling) and function (RNA sequencing [RNA-seq]) of the gut microbiota following immunization and subsequent exposure to wild-type Salmonella enterica serovar Typhi in a human challenge model to further investigate the central hypothesis that clinical outcomes may be linked to the gut microbiota. Metatranscriptome analysis of longitudinal stool samples collected from study subjects revealed two stable patterns of gene expression for the human gut microbiota, dominated by transcripts from either Methanobrevibacter or a diverse representation of genera in the Firmicutes phylum. Immunization with one of two live oral attenuated vaccines against S. Typhi had minimal effects on the composition or function of the gut microbiota. It was observed that subjects harboring the methanogen-dominated transcriptome community at baseline displayed a lower risk of developing symptoms of typhoid following challenge with wild-type S. Typhi. Furthermore, genes encoding antioxidant proteins, metal homeostasis and transport proteins, and heat shock proteins were expressed at a higher level at baseline or after challenge with S. Typhi in subjects who did not develop symptoms of typhoid. These data suggest that functional differences relating to redox potential and ion homeostasis in the gut microbiota may impact clinical outcomes following exposure to wild-type S. Typhi.IMPORTANCES. Typhi is a significant cause of systemic febrile morbidity in settings with poor sanitation and limited access to clean water. It has been demonstrated that the human gut microbiota can influence mucosal immune responses, but there is little information available on the impact of the human gut microbiota on clinical outcomes following exposure to enteric pathogens. Here, we describe differences in the composition and function of the gut microbiota in healthy adult volunteers enrolled in a typhoid vaccine trial and report that these differences are associated with host susceptibility to or protection from typhoid after challenge with wild-type S Typhi. Our observations have important implications in interpreting the efficacy of oral attenuated vaccines against enteric pathogens in diverse populations.Entities:
Keywords: 16S rRNA gene profiling; Salmonella; immunization; metatranscriptomics; methanogens; microbiome; typhoid disease
Mesh:
Substances:
Year: 2018 PMID: 29739901 PMCID: PMC5941076 DOI: 10.1128/mBio.00686-18
Source DB: PubMed Journal: MBio Impact factor: 7.867
FIG 1 16S rRNA profiling of longitudinal samples. (A) Longitudinal 16S rRNA data were used as input for an in-house k-means clustering pipeline. Vertical side bars (green, red, and blue) represent three clusters that were identified. These clusters are dominated by (i) Faecalibacterium, (ii) Faecalibacterium and Bacteroides, and (iii) Firmicutes, respectively. Horizontal side bars are color coded as follows: blue, Firmicutes; red, Bacteroidetes; green, Actinobacteria; purple, Proteobacteria; gray, Verrucomicrobia; brown, Euryarchaeota; orange, other. (B and C) Shannon diversity was calculated for each community (B) and clinical outcome (no TD [NTD] or TD) (C). (D) Relationship between genera was assessed by Spearman’s rank correlation coefficient using average genus abundances at baselines. The size and color of circles represent the correlation shown in the color bar. (E) Bray-Curtis dissimilarity values were calculated and compared between different subjects at the same time point (i.e., interindividual) as well as within each individual among different time points (i.e., intraindividual).
FIG 2 Metatranscriptome profiling of longitudinal samples. (A) Longitudinal metatranscriptome data were used as input for an in-house k-means clustering pipeline. Vertical side bars (red and blue) represent two community types that were identified: methanogen-dominated and diverse Firmicutes, respectively. Horizontal side bars are color coded as follows: blue, Firmicutes; red, Euryarchaeota; green, Bacteroidetes; purple, Actinobacteria; gray, Proteobacteria; brown, Verrucomicrobia. (B) Shannon diversity values were calculated for the two communities and were significantly different (P values ≤ 0.01). (C) Shannon diversity values calculated between the two clinical outcomes (no TD [NTD] or TD) were not significantly different (P values = 0.15). (D) Relationship between genera was assessed by Spearman’s rank correlation coefficient using average genus abundances at baselines. Size and color of circles represent the correlation shown in the color bar. (E) Principal-component analysis was applied to visualize dissimilarities among samples.
FIG 3 RNA-seq transcript dynamics and dissimilarity across subjects. (A) Relative genus abundance for each subject over time. D and M stand for diverse and Methanobrevibacter-dominated community, respectively. (B) Bray-Curtis dissimilarity for each of the subjects in this study. Each box plot represents the dissimilarity in the composition of the microbiota between all longitudinal samples collected from the same subject. Five statistical values are indicated on each box plot, including minimum, first quartile, median, third quartile, and maximum. (C) Bray-Curtis dissimilarity values were calculated and compared among different subjects at the same time point (i.e., interindividual) as well as within each individual among different time points (i.e., intraindividual).
FIG 4 Comparative analysis of RNA-seq data at baseline. (A) Shannon diversities of the two transcriptome communities were significantly different (P < 0.001). (B) Relative abundances of genera in each transcriptome community. Genera with significantly different abundances between the two communities are denoted with asterisks. (C) Number of unique and common KEGG orthologues detected in each transcriptome community. (D) Gene ontology groups that were significantly different between the two transcriptome communities are shown (false discovery rate, ≤0.05).
Mean relative abundance of genera at different time points
| Genus | Baseline | Postvaccine | Postchallenge | |||
|---|---|---|---|---|---|---|
| No TD | TD | No TD | TD | No TD | TD | |
| 0.069 | 0.071 | 0.084 | 0.127 | 0.066 | 0.079 | |
| 0.090 | 0.081 | 0.088 | 0.074 | 0.094 | 0.100 | |
| 0.048 | 0.082 | 0.048 | 0.077 | 0.0451 | 0.0871 | |
| 0.075 | 0.052 | 0.055 | 0.051 | 0.048 | 0.055 | |
| 0.0282 | 0.0692 | 0.0303 | 0.0613 | 0.0354 | 0.0734 | |
| 0.014 | 0.015 | 0.040 | 0.018 | 0.015 | 0.026 | |
| 0.021 | 0.016 | 0.019 | 0.015 | 0.018 | 0.021 | |
| 0.009 | 0.011 | 0.007 | 0.012 | 0.010 | 0.015 | |
| 0.315 | 0.180 | 0.346 | 0.170 | 0.3675 | 0.1425 | |
| 0.071 | 0.114 | 0.065 | 0.075 | 0.050 | 0.080 | |
| 0.052 | 0056 | 0.0286 | 0.0636 | 0.034 | 0.059 | |
| 0.025 | 0.029 | 0.018 | 0.025 | 0.0217 | 0.0387 | |
| 0.010 | 0.037 | 0.0068 | 0.0408 | 0.019 | 0.030 | |
| 0.0209 | 0.0489 | 0.025 | 0.050 | 0.01610 | 0.03510 | |
| 0.017 | 0.029 | 0.012 | 0.028 | 0.043 | 0.050 | |
| 0.011 | 0.017 | 0.013 | 0.016 | 0.020 | 0.018 | |
| 0.006 | 0.011 | 0.007 | 0.013 | 0.006 | 0.014 | |
| 0.008 | 0.017 | 0.010 | 0.009 | 0.008 | 0.010 | |
Pairs with a P value of ≤0.1 are denoted by superscript numbers, and the corresponding genera are marked in bold. Superscript numbers correspond to P values as follows: 1, P = 0.075; 2, P = 0.033; 3, P = 0.097; 4, P = 0.057; 5, P = 0.058; 6, P = 0.061; 7, P = 0.021; 8, P = 0.078; 9, P = 0.071; 10, P = 0.091.
FIG 5 Significant differences in the gene expression profiles between no-TD and TD subjects at baseline (BL), 1 day postchallenge (Post-chall 1D), or 7 days postchallenge (Post-chall 7D).